The FDFT1 gene gives your body instructions for making squalene synthase, an enzyme needed early in cholesterol production. This gene helps your body build cell membranes, make some hormones, and support brain and eye development. If the gene does not work properly, the body may not make enough cholesterol-based building blocks, which can lead to developmental delays, seizures, vision problems, or other differences present from birth.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
FDFT1Gene function
What if the gene works
The FDFT1 gene helps your body make cholesterol by carrying out an early step in the pathway. This supports cell membranes, hormone production, and other substances your body needs.
Risk
What if the gene does not work
Variants in the FDFT1 gene can cause a rare condition with developmental delay, seizures, stiffness, and walking problems. Milder and more severe variants can influence when symptoms appear and how marked they are.
Treatment
What does that mean for your treatment
No treatment plan or drug choice is currently guided specifically by a pathogenic variant in the FDFT1 gene, and care is based on the person’s symptoms and medical needs. The FDFT1 gene is being studied as a drug target in cholesterol conditions and some cancers, but this has not led to an established treatment approach for inherited FDFT1-related conditions.
Gene function
What if the gene works
Your cells use the FDFT1 gene during an early step of cholesterol production in the body. It helps turn smaller fat-like molecules into squalene, an oily building block used to make cholesterol. This supports everyday cell function because cholesterol is part of cell membranes and other important body chemicals.
The FDFT1 gene helps your cells join two smaller molecules to make squalene, an oily building block used to make cholesterol. This is one of the earliest points where the cell commits to the cholesterol-making route.
Inside your cells, the FDFT1 gene helps steer shared raw materials toward cholesterol production rather than other uses. This keeps that production pathway moving in an organized, step-by-step way.
By supporting cholesterol supply, the FDFT1 gene helps cells build and maintain healthy outer membranes. These membranes need the right cholesterol balance to stay stable, flexible, and able to send signals.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the FDFT1 gene change the shape or stability of squalene synthase, so cells make less working enzyme or an enzyme that works poorly. This is how variants in the FDFT1 gene affect protein function: some changes leave partial activity, while more disruptive variants can sharply reduce or stop enzyme activity altogether. In the rare condition linked to biallelic FDFT1 variants, lower remaining activity may be associated with earlier or broader features.
How variants are linked to conditions
Pathogenic variants in the FDFT1 gene are linked to a very rare inherited condition called squalene synthase deficiency. In reported families, this condition can lead to developmental delay or intellectual disability, seizures, movement problems such as dystonia, and sometimes eye findings like cataracts or hearing loss. These are the main health conditions linked to FDFT1 gene variants, and finding disease-causing variants in both copies of the gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the FDFT1 gene. If a change in FDFT1 is found, risk usually depends more on the exact genetic change and the health condition involved than on lifestyle or environmental factors.
Inheritance of FDFT1 variants
FDFT1-related conditions are inherited in an autosomal recessive pattern. This means a child inherits one FDFT1 gene variant from each parent, and both parents are usually healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. This pattern of inheritance of FDFT1 gene variants affects males and females equally.
What does my FDFT1 result mean for my family?
For families with an FDFT1-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether the same gene change is present in their family, especially when planning children. The meaning for relatives depends on the exact test result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the FDFT1 gene, doctors use FDFT1 genetic testing on a blood sample or saliva. A lab reads the DNA code in the gene, looks for variants, and compares them with known findings to report whether a variant is linked to disease, likely benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for FDFT1 may be considered when a child has unexplained developmental delay, seizures, low muscle tone, or eye and skin problems, especially if doctors suspect a very rare inherited condition affecting cholesterol production. It can also be relevant when similar symptoms run in the family or parents are blood relatives.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies based on the condition and the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, or moves a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medication or how sensitive they are to side effects. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medications. By studying links between genes and drugs, this field helps explain why the same treatment may not work the same way for everyone. For many medicines, genes can influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are both better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the FDFT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
The FDFT1 gene entered human genetics through decades of work on how the body makes cholesterol and related fats. In recent decades, awareness of this gene’s role has grown as researchers linked it to the long studied enzyme called squalene synthase, a key milestone in mapping the cholesterol pathway. Building on this early work, scientists cloned the human gene and placed it on chromosome 8, which helped connect older biochemistry findings with modern genetics. Interest in the FDFT1 gene also increased when drug researchers explored squalene synthase as a possible cholesterol lowering target. More recently, rare inherited variants in the FDFT1 gene have brought it into clinical genetics as understanding has become more precise.